Anti-Inflammatory Biologics Market to Gain Strongly; Approval of Novel Therapies to Augment Support Industry Visions, states Fortune Business Insights™

The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019.

Get Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/anti-inflammatory-biologics-market-102733

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Regional Analysis:

Increasing Cases of Inflammatory Diseases to Boost Growth in North America

The market in North America stood at USD 28.63 billion in 2019. The growth of the region is attributed to rising government support for the introduction of biosimilars in the region. The potential pipeline candidates along with demand for anti-TNF drugs will aid healthy growth of the market in the region.  The increasing prevalence of rheumatoid arthritis will spur demand for the market in North America. The approval of novel drugs will favor growth in Europe in the foreseeable future. For instance, in October 2018, Mylan announced the commercial launch of Hulio, a biosimilar of adalimumab. Asia Pacific is predicted to grow rapidly during the forecast period owing to the growing geriatric population. The increasing preference for biologics for inflammatory diseases will boost the market in Asia Pacific. The Middle East and Africa is likely to rise steadily in the forthcoming years owing to the improving healthcare infrastructure and rising disposable income.

Speak To Our Analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anti-inflammatory-biologics-market-102733

Key Development:

December2019: Amgen, an American multinational biopharmaceutical company headquartered in Thousand Oaks, California, introduced Avsola, a biosimilar of infliximab, after receiving approval from the USFDA.

July 2017: Janssen Biotech, a biotechnology company and also subsidiary of Johnson & Johnson announced that it has received the FDA approval for Tremfyain the treatment of plaque psoriasis.

Quick Buy – Anti-Inflammatory Biologics Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/102733

Table Of Contents :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Rheumatoid Arthritis & Psoriasis – For Key Countries
    • Pipeline Analysis
    • Patent Snapshot
    • New Product Launches
    • Key Industry Developments – Mergers, Acquisitions and Partnerships
  • Global Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Anti-Tumor Necrosis Factor (TNF)
      • Interleukin Antagonists
      • Janus Kinase (JAK) Inhibitors
      • Others
    • Market Analysis, Insights and Forecast – By Application
      • Rheumatoid Arthritis
      • Psoriasis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
        • Subcutaneous
        • Intravenous
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Anti-Tumor Necrosis Factor (TNF)
      • Interleukin Antagonists
      • Janus Kinase (JAK) Inhibitors
      • Others
    • Market Analysis, Insights and Forecast – By Application
      • Rheumatoid Arthritis
      • Psoriasis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
        • Subcutaneous
        • Intravenous
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
      • Canada
  • Europe Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Anti-Tumor Necrosis Factor (TNF)
      • Interleukin Antagonists
      • Janus Kinase (JAK) Inhibitors
      • Others
    • Market Analysis, Insights and Forecast – By Application
      • Rheumatoid Arthritis
      • Psoriasis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
        • Subcutaneous
        • Intravenous
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Countries/ Sub-region
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Scandinavia
      • Rest of Europe
  • Asia Pacific Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Anti-Tumor Necrosis Factor (TNF)
      • Interleukin Antagonists
      • Janus Kinase (JAK) Inhibitors
      • Others
    • Market Analysis, Insights and Forecast – By Application
      • Rheumatoid Arthritis
      • Psoriasis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
        • Subcutaneous
        • Intravenous
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Countries/ Sub-region
      • Japan
      • China
      • India
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific

Toc Continue..

Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/enquiry/customization/anti-inflammatory-biologics-market-102733

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

LinkedIn: https://www.linkedin.com/company/fortune-business-insights

Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

 

Read Press Release: https://www.fortunebusinessinsights.com/press-release/anti-inflammatory-biologics-market-9881

Leave a Reply

Your email address will not be published. Required fields are marked *